| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.10. | HEALTHY EXTRACTS INC.: Healthy Extracts' Imaraïs Health & Beauty Products Now Available at 4,000 Additional Pharmacies Nationwide | 1.803 | ACCESS Newswire | New Major Retail Chain Launch Marks Healthy Extracts' Entrance of $730 Billion Beauty & Personal Care Market, with Additional International B2B Customer Wins in the Pipeline HENDERSON, NV / ACCESS Newswire... ► Artikel lesen | |
| HEALTHY EXTRACTS Aktie jetzt für 0€ handeln | |||||
| 14.10. | DHDL - HyEx: Wenn der wichtigste Satz nicht gesagt werden darf | 1 | deutsche-startups.de | ||
| 12.10. | DHDL - Ajambow, Cropsta, Hottey, Senor Lopez, HyEx, FoodFor treten vor die Löwen | 1 | deutsche-startups.de | ||
| 18.09. | HEALTHY EXTRACTS INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.08. | HEALTHY EXTRACTS INC.: Healthy Extracts Q2 2026 Net Revenue Up 113% to Record $2.1 Million, Driving Adj. EBITDA of $290,000 or $0.02 per Share | 1.134 | ACCESS Newswire | Strong Growth Outlook Enhanced by Acquisition of Sommer Ray's Imaraïs Beauty, Bringing a New Global Brand Presence Along with Major National and International B2B Wins1H-2026 Net Revenues Reached Record... ► Artikel lesen | |
| 14.08. | HEALTHY EXTRACTS INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 06.08. | HEALTHY EXTRACTS INC.: Healthy Extracts Sees First Half 2026 Net Revenue Up More Than 93% to Record $3.6 Million+ | 660 | ACCESS Newswire | Continued Strong 2026 Outlook Enhanced by Acquisition of Sommer Ray's Imaraïs Beauty, Delivering Major National B2B Customer Wins LAS VEGAS, NV / ACCESS Newswire / August 6, 2026 / Healthy Extracts... ► Artikel lesen | |
| 13.07. | HEALTHY EXTRACTS INC. - 8-K, Current Report | 3 | SEC Filings | ||
| 06.07. | HEALTHY EXTRACTS INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 21.05. | Healthy Extracts: Imaraïs Beauty Acquisition Expands Reach Into $730 Billion Beauty Market | 1 | pulse2.com | ||
| 19.05. | Healthy Extracts acquires Imaraïs Beauty, raises revenue run-rate outlook | 3 | Seeking Alpha | ||
| 19.05. | Healthy Extracts acquires Imaraïs Beauty for $24M revenue target | 2 | Investing.com | ||
| 19.05. | HEALTHY EXTRACTS INC.: Healthy Extracts Acquires Sommer Ray's Global Health & Beauty Brand, Imaraïs Beauty | 916 | ACCESS Newswire | Deal Marks Healthy Extracts' Entrance of $730 Billion Beauty & Personal Care MarketIncreases Company's 2026 Annualized Revenue Run Rate Outlook by 20% to $24 Million HENDERSON, NV / ACCESS Newswire... ► Artikel lesen | |
| 18.05. | HEALTHY EXTRACTS INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.05. | Healthy Extracts GAAP EPS of -$0.01, revenue of $1.6M | 1 | Seeking Alpha | ||
| 14.05. | HEALTHY EXTRACTS INC. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 14.05. | HEALTHY EXTRACTS INC.: Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA | 584 | ACCESS Newswire | 2026 Outlook Strengthened by New Major Global Partnership with Sommer Ray's Imaraïs Beauty and Entrance into $730 Billion Health & Beauty Market LAS VEGAS, NV / ACCESS Newswire / May 14, 2026 / Healthy... ► Artikel lesen | |
| 16.04. | HEALTHY EXTRACTS INC.: Healthy Extracts' Gummy USA Secures Major U.S. Manufacturing Partnership with Imaraïs Beauty | 645 | ACCESS Newswire | Initial Production Order includes Initial Five SKUs for 4,800+ Premier Isle End-Cap Placements at a Leading National Retailer, Supporting Rapid Expansion in the $720 Billion Health & Beauty Market LAS... ► Artikel lesen | |
| 08.04. | HEALTHY EXTRACTS INC.: Healthy Extracts Reports 2025 Net Revenue Up 45% to Record $4.5 Million | 701 | ACCESS Newswire | 2025 Non-GAAP Net Income Totaled $162,000 or $0.02 Per ShareRecord Results Driven by Fifth Sequential Quarter of Record-Setting Revenues, with the Momentum Setting Stage for Another Year of Double-Digit... ► Artikel lesen | |
| 02.04. | HEALTHY EXTRACTS INC.: Healthy Extracts Reports Preliminary 2025 Results, Net Revenue Expected Up 45% to Record $4.5 Million | 448 | ACCESS Newswire | Strong Annual Results Driven by Record-Setting Revenues for Fifth Quarter in a Row, Setting Stage for Another Record Year in 2026 LAS VEGAS, NV / ACCESS Newswire / April 2, 2026 / Healthy Extracts... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 42,890 | 0,00 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,400 | -2,58 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 66,97 | +0,12 % | BrightSpring projects at least $700M 2026 operating cash flow while reiterating 15%-20% 2027 organic adjusted EBITDA growth | ||
| FRESENIUS | 47,795 | +1,69 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Fresenius mit einem Kursziel von 55,20 Euro auf "Overweight" belassen. Für die Quartalszahlen des Medizinkonzerns am 4. November liege er beim... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 7,280 | +0,14 % | Alignment Healthcare lowers 2026 outlook as it navigates cost headwinds | ||
| HEARTFLOW | 59,11 | +0,10 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| GERRESHEIMER | 32,040 | +0,44 % | JPMORGAN stuft GERRESHEIMER AG auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Gerresheimer mit einem Kursziel von 46 Euro auf "Overweight" belassen. David Adlington passte sein Bewertungsmodell für den Verpackungsspezialisten... ► Artikel lesen | |
| GENEDX | 69,04 | -0,03 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| CARL ZEISS MEDITEC | 34,980 | +0,63 % | Weniger Blendung bei 64 Prozent der Testpersonen: Wie ZEISS Licht im Brillenglas steuert | ||
| LIFESTANCE HEALTH GROUP | 13,410 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| PROGYNY | 29,210 | +0,07 % | Progyny's (PGNY) Full-Year Guidance Lowered on Utilization Headwinds | ||
| BETA BIONICS | 16,730 | -0,12 % | Truist reiterates Buy on Beta Bionics stock, $28 target on MINT | ||
| BILLIONTOONE | 113,21 | -0,10 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| DRAEGERWERK | 102,00 | -3,23 % | EQS-DD: Drägerwerk AG & Co. KGaA: Dr. Heinrich Dräger GmbH, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
28.10.2026 / 11:57... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,490 | +0,05 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |